TYMLOS 3120 mcg in 1.56 mL Pen Injector
RxNorm 1921081
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1921081 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: TYMLOS 3120 mcg in 1.56 mL Pen Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1.56 mL abaloparatide 2 mg/ML Pen Injector [Tymlos]
(Atom ID: 9179031)
SYPrescribable
Synonym (SY):
Tymlos 2000 mcg/ML per 1.56 mL Pen Injector
(Atom ID: 9179034)
PSNPrescribable
Prescribable Name (PSN):
TYMLOS 3120 mcg in 1.56 mL Pen Injector
(Atom ID: 9179032)
SYPrescribable
Synonym (SY):
Tymlos 3120 mcg per 1.56 mL Pen Injector
(Atom ID: 9179033)
SYPrescribable
Synonym (SY):
Tymlos 80 mcg per 0.04 mL Pen Injector
(Atom ID: 9192446)
Patient Education
Abaloparatide Injection
Abaloparatide injection is used to treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause ('change in life,' end of menstrual periods), who are at high risk of fractures (broken bones) or who could not be treated successfully with other medications. Abaloparatide injection contains a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by causing the body to build new bone and by increasing bone strength and density (thickness).
[Learn More]
* Please review the disclaimer below.